Skip to content

Patients use device to monitor AMD at home

Data could help guide treatment
July 16, 2021
Age-Related Macular Degeneration Artificial Intelligence Imaging
Clinical Research
NEI
DECA - Clinical Trials Branch DECA - Epidemiology Branch

Tiarnan Keenan

Tiarnan Keenan, NEI Division of Epidemiology and Clinical Applications, and colleagues found that people with age-related macular degeneration (AMD) can successfully use the Notal Home OCT device to monitor their disease. The device is part of a system developed by Notal Vision that uses artificial intelligence to measure fluid in the retina. Data from the system will help inform treatment decisions.